PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2013 | 20 | 2 |

Tytuł artykułu

Lipid pattern in middle-aged inhabitants of the Lower Silesian region of Poland. The PURE Poland sub-study

Treść / Zawartość

Warianty tytułu

Języki publikacji

EN

Abstrakty

EN
Introduction. A decreased serum high density lipoprotein-cholesterol (HDL-C) is a strong predictor of cardiovascular risk. However, total HDL is a very dynamic, changeable fraction, and does not perform the function of atherosclerosis markers. In the presented study, the pattern of serum lipids, including HDL-C subclasses (HDL2- and HDL3-cholesterol), in a middleaged Polish Lower Silesia population was defined. Materials and method. A group of 746 males and 1,298 females, aged 35–70, were investigated. All subjects were participants in the PURE study. Mean serum lipid levels were determined for groups selected on the basis of gender, age, cigarette smoking, drinking alcohol and place of residence (urban/rural area). The data were analyzed using STATISTICA 6.0 PL. Results. In multiple linear regression models, age was the most important independent and consistent predictor of total cholesterol (TC) and LDL cholesterol (LDL-C). The prevalence of low HDL-C (threshold 40 mg/dL in males, 50 mg/dL in females) was 16.5% for males and 22.6% for females. This gender-conditioned difference in the prevalence of low HDL-C was greater in rural (20.0% vs. 30.9%, respectively, in males and females) in comparison to urban (14.4% vs. 17.1%) areas. The lipid pattern was significantly worse in rural than in urban females. Female rural inhabitants showed higher triglycerides (TG) and lower HDL cholesterol (total and contained in subclasses HDL2 and HDL3). Simultaneously, a higher BMI, higher percent of smokers and drinkers and lower age of smoking female rural inhabitants in comparison to urban females were estimated. In the total population, cigarette smoking or drinking alcohol were associated with significant increases in TC, LDL-C and TG, also with decreased HDL-C (smoking) or HDL2-C (drinking). Two-way analysis of variance showed the existence of interaction between these risk factors in their influence on HDL-C and HDL3-C. Conclusion. In the middle-aged population of the Lower Silesian region in Poland the place of residence (urban/rural area) had a significant impact on the lipid pattern. This pattern is more atherogenic in rural women than in urban women.

Wydawca

-

Rocznik

Tom

20

Numer

2

Opis fizyczny

p.317-324,fig.,ref.

Twórcy

  • Department of Internal and Occupational Medicine and Hypertension, Wroclaw Medical University, Wroclaw, Poland
  • Department of Internal and Occupational Medicine and Hypertension, Wroclaw Medical University, Wroclaw, Poland
autor
  • Department of Internal and Occupational Medicine and Hypertension, Wroclaw Medical University, Wroclaw, Poland
autor
  • Department of Social Medicine, Wroclaw Medical University, Wroclaw, Poland
autor
  • Department of Social Medicine, Wroclaw Medical University, Wroclaw, Poland
  • Department of Dietetics, Wroclaw Medical University, Wroclaw, Poland
autor
  • Department of Food Science and Dietetics, Wroclaw Medical University, Wroclaw, Poland
autor
  • Department of Internal and Occupational Medicine and Hypertension, Wroclaw Medical University, Wroclaw, Poland
autor
  • Cancer Epidemiology and Prevention Division, The Maria Sklodowska-Curie Memorial, Cancer Center and Institute of Oncology, Warsaw, Poland

Bibliografia

  • 1. European Heart Network. Cardiovascular disease statistics. http://www.ehnheart.org 2008 edition.
  • 2. Panico S, Mattiello A. Epidemiology of cardiovascular diseases in women in Europe. Nutrition, Metabolism Cardiovascular Dis. 2010; 20: 379–85.
  • 3. Fogarty P, O’Beirne B, Casey C. Epidemiology of the most frequent diseases in the European a-symptomatic post-menopausal women. Isthere any difference between Ireland and the rest of Europe? Maturitas2005; 52S: S3-S6.
  • 4. Despres JP, Lemieux I, Dagienais GR, et al. HDL-cholesterol as a marker of coronary heart disease risk: the Quebec cardiovascular study.Atherosclerosis 2000; 153: 263–72.
  • 5. Tanne D, Yari S, Goldbourt U. High- density lipoprotein cholesterol and risk of ischemic stroke mortality. A 21- year follow-up of 8586 menfrom the Israeli Ischemic. Heart Disease Study. Stroke 1997; 281: 83–87.
  • 6. Veverling-Rijnsburger AW, Jonkers IJ, van Exel E, Gussekloo J, Westerdrop RG. High density vs low density lipoprotein cholesterolas the risk factor of coronary artery disease ad stroke in old age. ArchIntern Med. 2003; 163(13): 1549–54.
  • 7. Pedersen TR, Olsson AG, Faergman O, et al. for The Scandinavian Simvastatin Survival Study Group. Lipoprotein changes and reductionin the incidence of major coronary heart disease events in theScandinavian Simvastatin Survival Study (4S) Circulation. 1998; 97:1453–60.
  • 8. Rubins HB, Robins SJ, Collins D, et al. for the Veterans Affairs High- Density Lipoprotein Cholesterol Intervention Trial Study Group.Gemfibrozil for the secondary prevention of coronary heart diseasein men with low levels of high-density lipoprotein cholesterol. N EnglJ Med. 1999; 341: 410–8.
  • 9. Oram JF. HDL apolipoproteins and ABCA1: partners in the removal of excess cellular cholesterol. Arterioscler Thromb Vasc Biol. 2003;23: 720–7.
  • 10. Barter P. HDL: a recipe for longevity. Atherosclerosis 2004; 5: 25–31.
  • 11. Murphy AJ, Chin-DustingJP, Sviridov D, Woolard KJ. The antiinflammatory effects of high density lipoproteins. Curr Med Chem. 2010; 16: 667–75.
  • 12. Kontush A, Therond P, Zerrad A, Couturier M, Negre-Salvayre A, de Souza JA, Chantepie S, Chapman MJ. Preferiential sphingosine-1-phosphate enrichment and sphingomyelin depletion are keyfeatures of small dense HDL3 particles: relevance to antiapoptoticand antioxidative activities. Ath Thromb Vasc. 2007; 27(8): 1843–9.
  • 13. Nofer JR, Levkau B, Wolinska I et al. Supression of endothelial cell apoptosis by high density lipoprotein (HDL) and HDL asssociatedlysosphingolipids. J Biol Chem. 2001; 276: 43480–5.
  • 14. Li D, Weng S, Yang B, Zander DS, Saldsen T, Nichols WW, Khan S, Metha JL. Inhibition of arterial thrombus formation by apo AI Milano.Arteriosc Thromb Vasc Biol. 1999; 19: 378–83.
  • 15. Nofer JR, Giet M, Tolle M, Wolinska I, Wnuck Lipinski K, et al. HDL induces NO-dependent vasorelaxation via the lysophospholipidreceptor S1P3. J Clin Invest. 2004; 113: 560–81.
  • 16. Nofer JR, Kehre B, Fobker M, Levkau B, Assman G, von Eckardstein A. HDL and arteriosclerosis: beyond reverse cholesterol transport.Atherosclerosis. 2002; 161: 1–16.
  • 17. Van Lenten BJ, Wagner AC, Nayak DP, Hama S, Navab M, Fogelman AM. High-density lipoprotein loses its anti-inflammatory propertiesduring acute influenza a infection. Circulatory 2001; 103: 2283–8.
  • 18. Gomaraschi M, Conca P, Favari E, Sinagra G, Bernini F, Franceschini G, Calabresi L. Relationship between inflammation-induced structuralchanges of HDL and atheroprotective functions. 6th IAS-SponsoredWorkshop on High Density Lipoproteins, Westin, Whisler, CanadaMay 17–20, 2010, Abstract Book, P-063.
  • 19. Smith JD. Myeloperoxidase, Inflammation, and Dysfunctional HDL. J Clin Lipidol. 2010; 4(5): 382–8.
  • 20. Le N, Epperson M, Gosmanova E, Gletsu N, Lin E, Wilson P. Acute changes in antioxidant properties of plasma high-density lipoproteins. 6th IAS-Sponsored Workshop on High Density Lipoproteins, Westin,Whisler, Canada, May 17–20, 2010, Abstract Book, P-070.
  • 21. Berg CM, Lissner L, Aires N, Lappas G, Tore´n K, Wilhelmsen L, et al. Trends in blood lipid levels, blood pressure, alcohol and smoking habitsfrom 1985 to 2002: results from INTERGENE and GOT-MONICA. EurJ Cardiovasc Prev Rehabil. 2005; 12: 115–125.
  • 22. Berns MAM, de Vries JHM, Katan MB. Determinants of the increase of serum cholesterol with age: a longitudinal study. Int J Epidemiol.1988; 17(4): 789–796.
  • 23. Ferrara A, Barrett-Connor E, Shan J. Total, LDL, and HDL cholesterol decrease with age in older men and women. The Rancho Bernardo Study1984–1994. Circulation. 1997; 96: 37–43.
  • 24. Freedman DS, Otvos JD, Jeyarajah EJ, Shalaurova I, Cupples LA, Parise H, et al. Sex and age differences in lipoprotein subclasses measured bynuclear magnetic resonance spectroscopy: the Framingham Study.Clin Chem. 2004; 50: 1189–1200.
  • 25. Ai M, Otokozawa S, Asztalos BF, Ito Y, Nakajima K, White CC, Cupples LA, Wilson PW, Schaefer EJ. Small dense LDL cholesterol and coronaryheart disease: results from the Framingham Offspring Study. ClinChem. 2010; 56(6): 967–76. Epub 2010 Apr.29
  • 26. Stone NJ, Bilek S, Rosenbaum S.Strona NCEPT ATP III. Recent National Cholesterol Education Program Adult Treatment Panel III update:adjustments and options. Am J Cardiol. 2005; 96(4A): 53E-59E.
  • 27. Rouvre M, Vol S, Gusto G, Born C, Lantieri O, Tichet J, Lecomte P. Low high density lipoprotein cholesterol: prevalence and associated riskfactorsin a large French population. Ann Epidemiol. 2011; 21(2): 118–27.
  • 28. Pannier B, Thomas F, Eschwe`ge E, Bean K, Benetos A, Leocmach Y, et al. Cardiovascular risk markers associated with the metabolic syndrome in a large French population: the SYMFONIE study. DiabetesMetab. 2006; 32: 467–474.
  • 29. Ostlund RE, Staten M, Kohrt WM, Schultz J, Malley M. The Ratio of Waist-to-Hip Circumference, Plasma Insulin Level, and Glucose Intolerance as Independent predictors of the HDL2 cholesterol levelin older adults. N J Eng Med. 1990; 322(4): 229–34.
  • 30. Kolovou GD, Anagnostopoulou K, Pilatis ND, et al. Fasting serum triglyceride and high-density lipoprotein cholesterol levels in patientsintended to be treated for dyslipidemia. Vasc Health Risk Manag.2005; 1: 155–61.
  • 31. Kolovou GD, Anagnostopoulou KK, Salpea KD, et al. Influence of triglycerides on other plasma lipids in middle-aged men intended forhypolipidaemic treatment. Hellenic J Cardiol. 2006; 47: 78–83.
  • 32. Pownall HJ, Brauchi D, Kilinç C, et al. Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activityand the neutral lipid compositions of high-density and low-densitylipoproteins. Atherosclerosis 1999; 143: 285–97.
  • 33. Denke MA, Sempos CT, Grundy SM. Excess body weight. An underrecognized contributor to dyslipidemia in white American women.Arch Intern Med. 1994; 154(4): 401–410.
  • 34. Jennings C, Kotseva K, De Backer G, Keil U, Wood D. Time trends in smoking in coronary patients the EUROASPIRE Surveys I, II and IIIin 8 countries. Eur J Cardiovasc Nurs. 2008; 7: S25–6.
  • 35. Gupta R. Recent trends in coronary heart disease epidemiology in India. Indian Heart J. 2008; 60(2 Suppl B): B4–18.
  • 36. Ruixing Y, Shangling P, Hong C, Hanjun Y, Hai W, Yuming C, Jinzhen W, Feng H, Meng L, Muyan L. Diet, alcohol consumption, and serumlipid levels of the middle-aged and elderly in the Guangxi Bai Ku Yaoand Han populations. Alcohol. 2008; 42(3): 219–29.
  • 37. Ruidavets JB, Ducimetière P, Evans A, Montaye M, Haas B, Bingham A, et al. Patterns of alcohol consumption and ischaemic heart diseasein culturally divergent countries: the Prospective EpidemiologicalStudy of Myocardial Infarction (PRIME). BMJ 2010; 341: c6077. doi:10.1136/bmj.c6077.
  • 38. Dai WS, Horn DL, Kuller LH, D’Antonio JA, Gutai JP, Wozniczak M, Wohlfahrt B. Alcohol consumption and high density lipoproteincholesterol concentration among alcoholics. Am J Epidemiol. 1985;122: 620–7.
  • 39. Mäkelä SM, Jauhiainen M, Ala-Korpela M, Metso J, Lehto TM, Savolainen MJ, Hannuksela ML. HDL2 of heavy alcohol drinkers enhances cholesterol efflux from raw macrophages via phospholipidrich HDL2b particles. Alkohol Clin Exp Res. 2008; 32(6): 991-1000.

Typ dokumentu

Bibliografia

Identyfikatory

Identyfikator YADDA

bwmeta1.element.agro-7b49c484-8fbc-44b1-adea-4049b1475c52
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.